SNX1 and colorectal cancer: Bian et al. found histologic evidence that SNX1 expression is downregulated in human colorectal cancer and reported that overexpression of SNX1 enhanced chemo-sensitivity of colorectal cancer cells to both 5-Fu and oxaliplatin (Bian et al., 2016).